PhD Uroš Urleb
no.: 01878

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy

Keywords

Medicinal chemistry, drug design, peptidomimetics, drug analysis, nir spectroscopy

Bibliography Representative bibliographic units | Personal | COBISS+

Evaluation (metodology)

Points

A''

A1/2

CI10

645

CImax

101

h10

Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024

Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	102	1,460	1,152	11.29
Scopus	107	1,698	1,375	12.85

Audiovisual sources

no.	Title (with video link)	Event	Source
1.

Mentoring junior researchers

no.	Name and surname	Type	Period	Code
1	PhD Tomaž Bratkovič	Uniform doctoral studies	1/1/2003 - 8/31/2005	23598
2	PhD Aleš Obreza	Doctoral degree	11/1/1998 - 5/31/2002	19061
3	KATARINA VERHNJAK	Master's degree	6/1/1992 - 5/31/1995	12633
4	VESNA LESKOVŠEK	Master's degree	4/1/1992 - 3/31/1995	12632

Doctoral dissertations and other final papers Show

Employments

Type of employment	Research org.	Research group
Full time employment (20%, RD:0%)	University of Ljubljana, Faculty of Pharmacy	Chair for Pharmaceutical Chemistry
Full time employment (100%, RD:100%)	Novartis Pharmaceutical Manufacturing LLC	Raziskovalna skupina Novartis d.o.o. (Slovene)

Research projects Legend

no.	Code	Title	Period	Head	No. of publications
1.	L2-1112	Tehnologije znanj za odkrivanje novih zdravilnih učinkovin: analiza in načrtovnje eksperimentov v visokozmogljivostni genetiki (Slovene)	2/1/2008 - 1/31/2011	PhD Blaž Zupan	3,262
2.	L1-9596	Molecular mechanism of novel hypolipidemics	7/1/2007 - 12/31/2008	PhD Uroš Urleb	1,887
3.	J1-7584	Novel Mur ligase inhibitors	9/1/2005 - 8/31/2008	PhD Uroš Urleb	1,133
4.	Z1-7586	Development of Mur Ligase Inhibitors as Novel Antibacterial Agents	9/1/2005 - 8/31/2007	PhD Uroš Urleb	411
5.	L1-6707	Design, synthesis and test of potencial hypolipidemic drugs with a new target	2/1/2004 - 1/30/2007	PhD Uroš Urleb	3,615
6.	L3-5084	Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)	1/1/2003 - 12/31/2005	PhD Mojca Stegnar	5,823
7.	L1-3261	Development of biologicaly active peptidomimetics	7/1/2001 - 12/31/2003	PhD Uroš Urleb	2,132
8.	L1-0469	Optimization of MDP and TNF analogues having therapeutic potential	7/1/1998 - 6/30/2000	PhD Anton Štalc	6,572
9.	J1-8889	Mimetics of biologically active peptides: Strategies of design and synthesis	1/1/1997 - 12/31/1999	PhD Danijel Kikelj	3,991
10.	L1-7379	Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)	1/1/1996 - 6/30/1998	PhD Anton Štalc	6,278
11.	J1-7053	Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene)	1/1/1995 - 6/30/1998	PhD Aleš Mrhar	7,221

ARIS research and infrastructure programmes Legend

no.	Code	Title	Period	Head	No. of publications
1.	P1-0340	Design and preclinical development of novel drugs	1/1/2014 - 12/31/2017	PhD Uroš Urleb	1,558
2.	P1-0340	Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)	1/1/2009 - 12/31/2013	PhD Uroš Urleb	936
3.	P1-0340	Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)	7/1/2006 - 12/31/2008	PhD Uroš Urleb	1,614
4.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	1/1/2004 - 12/31/2008	PhD Danijel Kikelj	6,551

We were not given permission by the researcher to publish data.